Recent News

By Category: Countermeasures

UTMB awarded $4.8M to develop vaccine for Junin virus

GALVESTON — Scientists at the University of Texas Medical Branch and the Scripps Research Institute in La Jolla, Calif., have received a five-year $4.8 million grant from the National Institute of Allergy and Infectious Diseases to produce a new, safer vaccine candidate for Junin virus, a deadly Argentine hemorrhagic fever pathogen identified as a potential  Read More »

WHO group finalizes landmark pandemic virus-sharing agreement

(CIDRAP News) – A World Health Organization (WHO) working group on influenza virus sharing capped off a week of negotiations with a final agreement that establishes a framework for sharing vaccine strains alongside a system for improving the flow of pandemic vaccine and medications to developing countries. The WHO said yesterday that the group, which  Read More »

DTRA is supporting a clinical study now underway by the USAMRIID to evaluate a vaccine against ricin toxin

The Defense Threat Reduction Agency (DTRA) is supporting a clinical study now underway by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to evaluate a vaccine against ricin toxin. This is a critical milestone for DTRA’s Chemical/Biological Technologies Directorate Translational Medicine Science & Technology Division (CBM) to support “first in human” evaluations of  Read More »

Duke Human Vaccine Institute signs research agreement to develop pandemic virus vaccines

(Duke University Medical Center) The Duke Human Vaccine Institute today announced a collaboration and strategic agreement with Novartis Vaccines and Diagnostics to enable the rapid development of a vaccine and accelerate preparedness in case of a pandemic virus threat such as pandemic influenza.

Surveillance at the genetic level: Is it possible? – GCN.com

DARPA is specifically interested in transdiscipline teams with expertise in mathematical disciplines associated with encryption, epigenetics and epigenetic control, genetic control elements, and synthetic biology,” the agency noted in its workshop…